scholarly journals DB1 PROJECTED COST-EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30 IN TYPE 2 DIABETES PATIENTS SWITCHED FROM BIPHASIC HUMAN INSULIN IN THE UNITED STATES

2009 ◽  
Vol 12 (3) ◽  
pp. A10 ◽  
Author(s):  
M Aagren ◽  
TL Thomsen ◽  
VK Knudsen
Sign in / Sign up

Export Citation Format

Share Document